Structure

InChI Key RVFUNJWWXKCWNS-UHFFFAOYSA-N
Smile CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl
InChI
InChI=1S/C14H22ClN3O2.ClH/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C14H25Cl2N3O3
Molecular Weight 354.28
AlogP 2.0
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 7.0
Polar Surface Area 67.59
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 20.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Dopamine D2 receptor antagonist Wikipedia FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Postoperative Nausea and Vomiting 4 D020250 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
37.53
General disorders and administration site conditions
9.07
Psychiatric disorders
8.66
Gastrointestinal disorders
5.59
Cardiac disorders
4.68
Injury, poisoning and procedural complications
4.51
Musculoskeletal and connective tissue disorders
4.43
Immune system disorders
3.87
Respiratory, thoracic and mediastinal disorders
3.44
Vascular disorders
3.17
Skin and subcutaneous tissue disorders
2.57
Metabolism and nutrition disorders
2.33
Investigations
2.21

Cross References

Resources Reference
ChEBI 6899
ChEMBL CHEMBL1200940
FDA SRS W1792A2RVD
Guide to Pharmacology 241
KEGG C07868
PubChem 441347
SureChEMBL SCHEMBL133509
ZINC ZINC01530716